Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter.
- Peter Giesecke,
- Mårten Rosenqvist,
- Viveka Frykman,
- Leif Friberg,
- Göran Wallin,
- Jonas Höijer,
- Stefan Lönn,
- Ove Törring
Thyroid 2017 Jul 5;27(7):878-885. Epub 2017 Jun 5.
6 Department of Clinical Research and Education, Sodersjukhuset, Karolinska Institutet , Stockholm, Sweden .
Background: Previous research has suggested an increased risk of death and cardiovascular disease in patients treated for hyperthyroidism. However, studies on this subject are heterogeneous, often based on old data, or have not considered the impact that treatment for hyperthyroidism might have on cardiovascular risk. It is also unclear whether long-term prognosis differs between Graves' disease and toxic nodular goiter. Read More